A positive dexamethasone suppression test (DST) means your blood cortisol level stayed above a certain threshold after you took a dose of dexamethasone, a synthetic steroid that should temporarily shut down your body’s cortisol production. In a healthy person, the drug signals the brain to stop calling for cortisol, so morning levels drop sharply. When they don’t drop enough, something is overriding that signal, and figuring out what that something is drives everything that follows. The answer can range from a medication you’re already taking to a rare hormone-producing tumor, which is why a single positive result is always the beginning of a workup, never the end of one.
How the Test Works
Your body produces cortisol in a daily rhythm: levels peak in the early morning and taper through the afternoon and night. Dexamethasone mimics cortisol closely enough to trick the brain’s control center into believing cortisol levels are already high, so the brain stops sending the hormone signal (ACTH) that tells the adrenal glands to make more. You swallow the dexamethasone tablet at around 11 p.m., then have blood drawn the next morning, usually at 8 a.m. If cortisol has dropped below the cutoff, the feedback loop is working normally and the result is called “negative.” If cortisol remains above the cutoff, the test is “positive,” meaning the normal feedback mechanism has been overridden.
The most widely used version is the overnight 1-mg DST. You take a single 1-mg tablet of dexamethasone at bedtime, and the morning blood draw measures serum cortisol. Both the overnight 1-mg DST and 24-hour urinary free cortisol collection are regarded as highly sensitive and specific first-line screening tools for Cushing’s syndrome.1PubMed. Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol-accuracy and pitfalls when screening for Cushing’s syndrome The test is popular because it is simple, inexpensive, and can be done at home with a single pharmacy prescription.
What Cortisol Level Counts as Positive
The standard cutoff for a positive result on the overnight 1-mg DST is a morning serum cortisol above 50 nmol/L (roughly 1.8 µg/dL). If your cortisol falls at or below that level, the test is considered negative. European guidelines for evaluating adrenal masses use this same threshold and recommend it as part of the initial workup for every patient with an adrenal incidentaloma.2European Journal of Endocrinology. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
That cutoff is chosen to be very sensitive, meaning it’s designed to catch nearly all true cases even at the cost of flagging some healthy people. A study of 80 patients with confirmed Cushing’s disease found that about 18% still suppressed their cortisol below 5 µg/dL on the overnight 1-mg test, and 8% even dropped below 2 µg/dL, despite genuinely having the disease.3The Journal of Clinical Endocrinology & Metabolism. The Low-Dose Dexamethasone Suppression Test: A Reevaluation in Patients with Cushing’s Syndrome In other words, the test can miss some real cases, which is part of why a single result never closes the book.
The Gray Zone and Mild Autonomous Cortisol Secretion
Not everyone who tests positive has full-blown Cushing’s syndrome. A growing area of concern involves people whose cortisol clears the 1.8 µg/dL threshold by only a small margin, often discovered incidentally when an adrenal mass is found on imaging done for an unrelated reason. The current term for this is “mild autonomous cortisol secretion,” or MACS. These individuals don’t look or feel like classic Cushing’s patients, but the subtle cortisol excess still appears to carry health consequences.
A large analysis of patients with adrenal incidentalomas found that post-DST cortisol above just 0.9 µg/dL was already associated with a higher risk of cardiovascular disease, with an adjusted odds ratio of about 2.2. Patients whose cortisol fell between 1.2 and 1.79 µg/dL had significantly higher rates of high blood pressure, diabetes, and cardiovascular events compared with those who suppressed below 1.2 µg/dL, even after accounting for age, weight, and cholesterol problems.4PubMed Central. Dexamethasone Suppression Testing in Patients with Adrenal Incidentalomas with/Without Mild Autonomous Cortisol Secretion: Spectrum of Cortisol Cutoffs and Additional Assays (An Updated Analysis) This means the line between “normal” and “abnormal” is not as sharp as a single number implies. Some endocrinologists are reconsidering whether the 1.8 µg/dL cutoff is too generous for spotting the kind of low-grade cortisol excess that gradually damages the heart and metabolic system.
Common Reasons for a False Positive
A positive DST does not automatically mean Cushing’s syndrome. A surprising number of factors can make cortisol look high even when your adrenal glands are working normally. Understanding these is critical because they account for a large share of positive results in everyday clinical practice.
Medications That Speed Up Dexamethasone Breakdown
Dexamethasone is broken down in the liver by an enzyme called CYP3A4. Certain drugs rev up that enzyme, causing your body to clear the dexamethasone too quickly. When the drug disappears before morning, cortisol has time to rebound, and the test reads positive even though the feedback loop is fine. Carbamazepine, a common seizure and mood-stabilizing medication, is a well-documented culprit: a case report in a 16-year-old male showed that carbamazepine accelerated dexamethasone metabolism enough to produce a convincingly positive result that mimicked Cushing’s syndrome.5PubMed Central. False Positive Cushing’s Syndrome in a 16-Year-Old Male Other CYP3A4 inducers, including phenytoin, rifampin, and certain older diabetes drugs, can do the same. One study showed that troglitazone (a now-withdrawn diabetes medication) reduced dexamethasone blood levels by about two-thirds through CYP3A4 induction, producing falsely abnormal DST results.6The Journal of Clinical Endocrinology & Metabolism. Troglitazone Induces CYP3A4 Activity Leading to Falsely Abnormal Dexamethasone Suppression Test
Oral Contraceptives and Estrogen
Estrogen-containing birth control pills are one of the most common causes of a false positive DST in younger women. Estrogen increases the liver’s production of cortisol-binding globulin, a protein that carries cortisol through the blood. Because standard lab assays measure total cortisol (both the bound and free forms), the result looks elevated even though the biologically active free cortisol may be perfectly normal.7PubMed. The influence of oral contraceptives on overnight 1 mg dexamethasone suppression test One study in women on oral contraceptives found that 63% had unclear or abnormal results after the standard overnight 1-mg DST, compared with only 27% after a two-day low-dose protocol, suggesting the longer test helps overcome this confounding effect.8PubMed Central. Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives Most clinicians will either ask patients to stop estrogen-containing pills at least six weeks before testing or will use a different screening approach entirely.
Pseudo-Cushing States
Several conditions activate the stress-hormone system chronically without there being a tumor or autonomous gland. Heavy alcohol use, severe obesity, poorly controlled diabetes, obstructive sleep apnea, and major depression can all push cortisol high enough to produce a positive screening test. These situations are sometimes called pseudo-Cushing states, and they can be genuinely difficult to distinguish from true Cushing’s syndrome. Standard measures like urine cortisol collection, cortisol rhythm assessment, and even the low-dose DST itself have been shown to fail at clearly classifying these patients.9PubMed. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states More specialized combined tests are often needed to tease the two apart.
Pregnancy
Pregnancy naturally raises cortisol levels substantially, driven by placental hormones. Dexamethasone doesn’t fully suppress cortisol in pregnant women even when no disease is present.10PubMed Central. The diagnosis and management of Cushing’s syndrome in pregnancy This makes the DST unreliable during pregnancy, and alternative approaches are needed if Cushing’s syndrome is suspected in a pregnant patient.
Checking Whether the Dexamethasone Actually Worked
One practical innovation that has improved DST accuracy is measuring the dexamethasone level in your blood at the same time as cortisol. If the dexamethasone level is too low, the test was essentially never given a fair shot, and the “positive” cortisol result is meaningless. Guidelines suggest the measured dexamethasone level should be above 200 ng/dL (4.5 nmol/L) for the result to be considered valid.11PubMed. Dexamethasone Suppression Test
This step catches problems like poor absorption (if you vomited after taking the pill), drug interactions that sped up metabolism, or simple non-compliance (forgetting to take the dose). One validation study found that accounting for adequate dexamethasone levels reduced the number of false-positive results substantially, preventing unnecessary further testing.12PubMed. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation Another study framed the simultaneous measurement of cortisol and dexamethasone as a way to both validate results and avoid unnecessary repeat testing.13PubMed Central. The Reflex Dexamethasone Suppression Test: Development and Assessment of Reflexed Serum Dexamethasone Measurement for the Diagnosis of Cushing Syndrome Not all labs measure dexamethasone levels routinely yet, but the practice is becoming more common.
Different Versions of the Test and What They Tell You
The overnight 1-mg DST is the most common screening version, but it’s not the only one. Each variant answers a slightly different clinical question.
The Two-Day Low-Dose Test
In this protocol, you take 0.5 mg of dexamethasone every six hours for 48 hours (eight doses total), with blood drawn at the end. It delivers a more sustained and predictable dexamethasone exposure, which makes it less susceptible to the absorption and metabolism problems that plague the single-dose overnight test. As mentioned, women on oral contraceptives fare much better on this version. However, some researchers have argued that even the standard 2-mg two-day protocol may miss patients with mild or periodic Cushing’s syndrome, and that an even lower dexamethasone dose of 0.25 mg might be more sensitive for these subtle cases.14PubMed Central. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism
The High-Dose Test
Once Cushing’s syndrome is confirmed, the next question is where the excess cortisol is coming from. The high-dose DST (typically 8 mg of dexamethasone overnight or spread over two days) helps distinguish between a pituitary source and an ectopic source, like a lung tumor producing ACTH. The logic: a pituitary tumor retains some sensitivity to feedback, so a large enough dose of dexamethasone can partially suppress it, whereas ectopic tumors typically ignore the signal entirely. In practice, a cortisol drop of 50% or more from baseline suggests pituitary origin.15PubMed. A very high dose dexamethasone suppression test for differential diagnosis of Cushing’s syndrome But this test is far from perfect, and some pituitary tumors don’t suppress even at high doses.16The Journal of Clinical Endocrinology & Metabolism. Effectiveness Versus Efficacy: The Limited Value in Clinical Practice of High Dose Dexamethasone Suppression Testing in the Differential Diagnosis of Adrenocorticotropin-Dependent Cushing’s Syndrome Many centers now supplement or replace it with a CRH stimulation test, which distinguished Cushing’s disease from ectopic ACTH with high accuracy in early validation studies, correctly identifying 29 of 33 pituitary cases and excluding all 8 ectopic cases.17Annals of Internal Medicine. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing’s syndrome
How the Lab Measures Cortisol Matters More Than You’d Think
Not all cortisol assays are created equal, and the measurement method can shift your result across the positive/negative line. Most hospital labs use automated immunoassays, which are fast and cheap but can cross-react with other steroid compounds in your blood. A more precise technique called liquid chromatography-tandem mass spectrometry (LC-MS/MS) avoids these cross-reactions but is more expensive and not universally available.
Recent head-to-head comparisons show that different immunoassay platforms can under- or overestimate cortisol relative to LC-MS/MS. One study found that a widely used immunoassay overestimated cortisol in baseline samples by about 32% and in post-DST samples by about 6%, while another platform underestimated by roughly 5–6%.18PubMed. Impact of old and current immunoassays on the 1 mg overnight dexamethasone suppression test: comparison with LC-MS/MS Both immunoassays detected lower rates of excess cortisol compared with LC-MS/MS in patients with adrenal masses, meaning they were more likely to miss real cases. Encouragingly, though, a separate study found that overall diagnostic performance between standard immunoassays and LC-MS/MS was comparable at optimized cutoffs, with areas under the curve above 0.95 for both methods when predicting overt cortisol excess.19PubMed. A new LC-MS/MS assay for serum cortisol, cortisone, and dexamethasone: real-world utility for the interpretation of the 1-mg overnight dexamethasone suppression test The practical takeaway: if your result is borderline, knowing which assay your lab used can matter, and some clinicians request LC-MS/MS for equivocal cases.
Adjusting the Test for Children
The flat 1-mg dose used in adults can actually over-suppress a small child, masking genuine disease, or produce unpredictable results in children of different sizes. Research dating back to early dose-finding studies showed that a dose of 0.3 mg per square meter of body surface area reliably suppressed cortisol in all tested children, whereas a lower dose of 0.1 mg per square meter only worked in some.20PubMed. Single dose dexamethasone suppression test in children: dose relationship to body size Pediatric endocrinologists generally calculate the dose based on body surface area rather than handing every child the same pill. The cutoff for interpreting the result remains the same, but getting the dose right is the tricky part in younger patients.
The DST’s Other Life in Psychiatry
Before the DST became a standard endocrine screening tool, it attracted enormous interest in psychiatry. Researchers in the early 1980s noticed that patients with severe depression often failed to suppress cortisol, and for a time the DST was proposed as the first biological test for a psychiatric diagnosis. A widely cited 1981 paper reported that the test had 67% sensitivity and 95% specificity for melancholic depression.21Europe PMC. Cortisol and the Dexamethasone Suppression Test as a Biomarker for Melancholic Depression: A Narrative Review Enthusiasm faded as it became clear the sensitivity was modest in the broader population of depressed patients, closer to 40–50%, though it climbed to 60–70% in very severe or psychotic forms of depression and mania.22PubMed. The dexamethasone suppression test: an overview of its current status in psychiatry
The psychiatric DST is mostly a historical curiosity today. It was never specific enough to serve as a standalone diagnostic tool, because too many non-depressed conditions (alcohol dependence, anorexia nervosa, severe stress) also cause non-suppression. But the research left an important legacy: it firmly established that severe mental illness can activate the stress-hormone system enough to confound an endocrine screening test. If you have a positive DST and also happen to have a major psychiatric illness, your clinician needs to factor that in before assuming a hormone-producing tumor is responsible.
When Veterinarians Order the Same Test
Dogs develop their own version of cortisol excess, called hyperadrenocorticism, and the low-dose dexamethasone suppression test is one of the main ways veterinarians diagnose it. The protocol is adapted for canine physiology: a different dose, blood draws at multiple time points (typically at 0, 4, and 8 hours post-injection), and interpretation based on suppression patterns rather than a single cutoff. Research into canine DST patterns has identified four distinct response types, including a classic lack of suppression (strongly indicative of disease), partial suppression, an escape pattern where cortisol initially drops but rebounds, and an inverse pattern. The strongest diagnostic value came from complete failure to suppress, which was essentially diagnostic, while partial suppression carried a positive likelihood ratio of about 8.23PubMed Central. Patterns of the low‐dose dexamethasone suppression test in canine hyperadrenocorticism revisited If your vet has mentioned this test for your dog, the underlying principle is the same as in humans, though the details differ enough that human reference ranges don’t apply.